Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) is based in China, with the head office in Shanghai. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on July 14, 2017. The total number of employees is currently 665 (2024). There was a net sales revenue increase of 47.96% reported in Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港))’s latest financial highlights for Q2C2025. Over the same period, its total assets decreased by 4.73%. The enterprise’s net profit margin increased by 153.75% in 2025.

Headquarters
Plaza 66, Tower 1, Units 6601-6606, 1266 West Nanjing Road
Shanghai; Shanghai; Postal Code: 200040

Contact Details: Purchase the Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) report to view the information.

Basic Information

Total Employees:

Purchase the Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) report to view the information.

Outstanding Shares:

Purchase the Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) report to view the information.

Registered Capital:

Purchase the Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) report to view the information.

Financial Auditors:

Purchase the Everest Medicines Limited (Hong Kong) (云顶新耀有限公司 (香港)) report to view the information.

Incorporation Date:

July 14, 2017

Key Executives